Expert InterviewIBB
Slingshot members are talking to an expert! The topic is:
An overview of next generation "oral biologics" in treating inflammatory/rheumatological disease
Executed on:Dec 8, 2022 4:00 PM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
Institution: Rheumatology Therapeutics Medical Center
- Rheumatologist at RTMC & Staff Physician at Cedar-Sinai Providence Tarzana Medical Center; fellowship trained at USC.
- Currently manages 500 patients with Rheumatoid Arthritis.
- Board Certified in both Rheumatology & Internal Medicine; Clinical focus on Rheumatoid Arthritis, Osteoarthritis, Spondyloarthropathies, Lupus, Scleroderma, Mixed Connective Tissue Disease, Sarcoidosis, Osteoporosis, Gout, Inflammatory Myopathies, and Vasculitis.
Interview Goal
The research field of oral successors to the immensely successful first generation of anti-inflammatory biologics (Humira, Remicade, Stelara etc) has yielded and will continue to produce blockbuster drugs. In this interview the focus will be to discuss the different classes of next generation oral inflammatory drugs, their weaknesses and strengths , differences and similarities, and which ones are likely to work in what disease.